T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.45B |
| 2 |
JPMorgan Chase
JPM
|
+$2.22B |
| 3 |
Atlassian
TEAM
|
+$2.08B |
| 4 |
NVIDIA
NVDA
|
+$1.81B |
| 5 |
Apple
AAPL
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.24B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.08B |
| 3 |
Microsoft
MSFT
|
+$2.68B |
| 4 |
Wells Fargo
WFC
|
+$1.93B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.86B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.79% |
| 2 | Healthcare | 17.2% |
| 3 | Consumer Discretionary | 15.17% |
| 4 | Financials | 10.75% |
| 5 | Communication Services | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GTHX
1851
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $1.33M | ﹤0.01% |
175,225
-659,202
| -79% | -$6.25M |
|
|
SJI
1852
DELISTED
South Jersey Industries, Inc.
SJI
| $1.33M | ﹤0.01% |
38,550
+5,691
| +17% | +$164K |
|
1853
FirstCash
FCFS
$9.14B
| $1.33M | ﹤0.01% |
18,916
-1,454
| -7% | -$103K |
|
1854
La-Z-Boy
LZB
$1.64B
| $1.33M | ﹤0.01% |
50,432
+5,183
| +11% | +$166K |
|
1855
Plexus
PLXS
$7.25B
| $1.33M | ﹤0.01% |
16,228
+1,065
| +7% | +$88.7K |
|
1856
BioCryst Pharmaceuticals
BCRX
$2.51B
| $1.32M | ﹤0.01% |
81,009
-6,836
| -8% | -$110K |
|
1857
COPT Defense Properties
CDP
$4.23B
| $1.31M | ﹤0.01% |
45,974
+6,858
| +18% | +$185K |
|
|
AVTA
1858
DELISTED
Avantax, Inc. Common Stock
AVTA
| $1.3M | ﹤0.01% |
66,699
+8,442
| +14% | +$153K |
|
|
FLOW
1859
DELISTED
SPX FLOW, Inc.
FLOW
| $1.3M | ﹤0.01% |
15,105
-19
| -0.1% | -$1.63K |
|
1860
Brinker International
EAT
$10.2B
| $1.3M | ﹤0.01% |
34,062
-119,754
| -78% | -$4.48M |
|
1861
Oscar Health
OSCR
$9.5B
| $1.3M | ﹤0.01% |
130,316
+2,000
| +2% | +$14.9K |
|
|
ARI
1862
Apollo Commercial Real Estate
ARI
$885M
| $1.3M | ﹤0.01% |
93,160
+3,123
| +3% | +$42.1K |
|
1863
Federal Agricultural Mortgage
AGM
$2.58B
| $1.29M | ﹤0.01% |
11,909
+3,656
| +44% | +$447K |
|
1864
Hyatt Hotels
H
$16.9B
| $1.29M | ﹤0.01% |
13,510
+3,924
| +41% | +$368K |
|
1865
Bread Financial
BFH
$4.51B
| $1.29M | ﹤0.01% |
22,932
+2,481
| +12% | +$163K |
|
|
ASTR
1866
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
| $1.29M | ﹤0.01% |
22,238
-16
| -0.1% | -$1.06K |
|
1867
Peoples Bancorp
PEBO
$1.48B
| $1.28M | ﹤0.01% |
40,936
+6,271
| +18% | +$203K |
|
1868
First Hawaiian
FHB
$3.36B
| $1.28M | ﹤0.01% |
45,943
+3,100
| +7% | +$89.5K |
|
|
MAXR
1869
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $1.27M | ﹤0.01% |
32,252
+3,117
| +11% | +$95.3K |
|
1870
First Bancorp
FBP
$4.49B
| $1.27M | ﹤0.01% |
96,737
+4,047
| +4% | +$57.6K |
|
1871
Diamondrock Hospitality Co
DRH
$2.5B
| $1.27M | ﹤0.01% |
125,542
+13,477
| +12% | +$130K |
|
1872
NBT Bancorp
NBTB
$2.78B
| $1.27M | ﹤0.01% |
35,066
+3,194
| +10% | +$124K |
|
1873
Stepan Co
SCL
$1.48B
| $1.27M | ﹤0.01% |
12,826
-148,039
| -92% | -$16M |
|
1874
Four Corners Property Trust
FCPT
$2.74B
| $1.26M | ﹤0.01% |
46,781
+1,709
| +4% | +$46K |
|
1875
iShares Core S&P Mid-Cap ETF
IJH
$128B
| $1.26M | ﹤0.01% |
23,565
| – | – |
|
Similar funds
T. Rowe Price Associates's Q1 2022 Portfolio in Review
As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
- T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
- T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
- T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
- T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
- T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.
Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.